In this study, we explored the effects of Pinometostat treatment in both MLL-r and non-MLL-r AML cells, and we compared the consequences of DOT1L inhibition in these genetically and biologically distinct AML models. The gene discussed is DOT1L; the disease is acute myeloid leukemia.